Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon May 12, 2021 11:15pm
158 Views
Post# 33189358

RE:RE:RE:RE:RE:RE:RE:VMD Share Price

RE:RE:RE:RE:RE:RE:RE:VMD Share Price

I added an estimate for June qtr. which is when the shares vest and new ones get issued.    Let's see if these guys are listening and drop the new issues.

Zehnder is out to lunch when he says Q2 phantom expense will be less than Q1.
 

Todd Zehnder
Yes, I think that your EBITDA margins will be back to normal for the rest of the year, really, and that’s going to—that will immediately come back to us. I think, G&A, we said it’s going to be flat for the rest of the year. For Q2, it very well could be down some, just like we had last year. I think it was 3Q was underneath what Q2 came in.
We are going to have less phantom expense in the third quarter—I mean, the second quarter than we did the first, but you’re right, we’re going to have some other initiatives that things are ramping back up.


 

 

Phantom sh plan

 

 

 

 

 

No of Shs o/s

Issued

Vested 

Expired

Jun30/21 (e)

571,000

350,000

700,000

30,000

Mar31/21

951,000

0

0

34,000

Dec31/20

985,000

0

0

34,000

Sep30/20

1,019,000

0

0

23,000

Jun30/20

1,042,000

346,000

601,000

31,000

Mar31/20

1,328,000

0

0

22,000

Dec31/19

1,350,000

0

0

33,000

Sep30/19

1,383,000

0

0

38,000

Jun30/19

1,421,000

351,000

550,000

17,000

Mar31/19

1,637,000

0

0

55,000

Dec31/18

1,692,000

0

0

29,000

Sep30/18

1,721,000

0

0

36,000

Jun30/18

1,757,000

1,793,000

0

36,000

Mar31/18

0

0

0

0

Dec31/17

0

 

 

 

 

<< Previous
Bullboard Posts
Next >>